CERE | Cerevel Therapeutics Holdings, Inc. | 轉虧為盈% | 轉虧為盈% |
CRSP | CRISPR Therapeutics AG | 轉虧為盈% | 3333233.3% |
RVMD | Revolution Medicines, Inc. | 轉虧為盈% | -95.2% |
BBIO | BridgeBio Pharma, Inc. | 35886.6% | 11461.9% |
RETA | Reata Pharmaceuticals, Inc. | 11273.7% | 2885% |
APLS | Apellis Pharmaceuticals, Inc. | 557.9% | 263.6% |
CYTK | Cytokinetics, Incorporated | 471.3% | -14.6% |
DHR | Danaher Corporation | 136.6% | -19.1% |
IBRX | ImmunityBio, Inc. | 104.9% | 90.4% |
BPMC | Blueprint Medicines Corporation | 103.6% | 51.9% |
GMAB | Genmab A/S | 93.3% | 45.2% |
BGNE | BeiGene, Ltd. | 69.3% | 67.9% |
IMGN | ImmunoGen, Inc. | 68.1% | 637.7% |
SRPT | Sarepta Therapeutics, Inc. | 66.2% | 63.1% |
HALO | Halozyme Therapeutics, Inc. | 40.4% | 20.8% |
IONS | Ionis Pharmaceuticals, Inc. | 39.1% | 113.5% |
OGN | Organon & Co. | 32.4% | 5.5% |
ALNY | Alnylam Pharmaceuticals, Inc. | 30.2% | 54.8% |
HLN | Haleon plc | 24.3% | -2.2% |
ARGX | argenx SE | 21.6% | 133.9% |
OSH | Oak Street Health, Inc. | 19.8% | 46.4% |
ELAN | Elanco Animal Health Incorporated | 15.5% | -4.1% |
NTRA | Natera, Inc. | 15.5% | 43.2% |
UTHR | United Therapeutics Corporation | 15.1% | 33.7% |
PODD | Insulet Corporation | 13.8% | 37.9% |
RPRX | Royalty Pharma plc | 12.9% | 5.3% |
PFE | Pfizer Inc. | 10.9% | -18.6% |
MRK | Merck & Co., Inc. | 10.7% | 9.1% |
GKOS | Glaukos Corporation | 10.7% | 15.9% |
DXCM | DexCom, Inc. | 10.4% | 24.2% |
OPCH | Option Care Health, Inc. | 10% | 12.8% |
ISRG | Intuitive Surgical, Inc. | 9.4% | 11.5% |
VRTX | Vertex Pharmaceuticals Incorporated | 8.6% | 13.3% |
ALGN | Align Technology, Inc. | 8.5% | 5.8% |
SWAV | ShockWave Medical, Inc. | 8.5% | 35.8% |
PHG | Koninklijke Philips N.V. | 8.4% | -0.7% |
DOCS | Doximity, Inc. | 8.2% | 17.4% |
BSX | Boston Scientific Corporation | 8.2% | 13.8% |
MOH | Molina Healthcare, Inc. | 7.5% | 21.9% |
GRFS | Grifols, S.A. | 7.4% | 3.3% |
TECH | Bio-Techne Corporation | 7.2% | 3.2% |
ZTS | Zoetis Inc. | 6.5% | 9.5% |
DGX | Quest Diagnostics Incorporated | 6.4% | 1.5% |
RDY | Dr. Reddy's Laboratories Limited | 6.3% | 6.6% |
NVS | Novartis AG | 6.1% | -10.4% |
INSP | Inspire Medical Systems, Inc. | 6.1% | 28.2% |
LH | Laboratory Corporation of America Holdings | 5.8% | -15.9% |
EXAS | Exact Sciences Corporation | 5.5% | 17% |
RMD | ResMed Inc. | 5.5% | 7.2% |
TFX | Teleflex Incorporated | 5.2% | 3.8% |
BDX | Becton, Dickinson and Company | 4.9% | 4.6% |
BRKR | Bruker Corporation | 4.8% | 5.3% |
HOLX | Hologic, Inc. | 4.7% | -0.8% |
BMY | Bristol-Myers Squibb Company | 4.7% | 4.7% |
EW | Edwards Lifesciences Corporation | 4.2% | 9.5% |
GMED | Globus Medical, Inc. | 4.2% | 119.3% |
LLY | Eli Lilly and Company | 4.2% | 26% |
RVTY | Revvity, Inc. | 4% | -3.7% |
BLCO | Bausch + Lomb Corporation | 3.9% | 18% |
ALC | Alcon Inc. | 3.8% | 14.2% |
RXDX | Prometheus Biosciences, Inc. | 3.8% | -71.8% |
ZBH | Zimmer Biomet Holdings, Inc. | 3.7% | 6.3% |
GILD | Gilead Sciences, Inc. | 3.6% | 5.3% |
EHC | Encompass Health Corporation | 3.6% | 13.4% |
IDXX | IDEXX Laboratories, Inc. | 3.5% | 7.1% |
UHS | Universal Health Services, Inc. | 3.5% | 10.8% |
COO | The Cooper Companies, Inc. | 3.4% | 8.5% |
MDT | Medtronic plc | 3.3% | 4.7% |
ATR | AptarGroup, Inc. | 3.2% | 6.4% |
ABC | AmerisourceBergen Corporation | 3.2% | 15% |
XRAY | DENTSPLY SIRONA Inc. | 3% | -2.6% |
REGN | Regeneron Pharmaceuticals, Inc. | 3% | -0.5% |
VEEV | Veeva Systems Inc. | 2.9% | 11.9% |
A | Agilent Technologies, Inc. | 2.9% | -5.6% |
HUM | Humana Inc. | 2.8% | 10.7% |
UNH | UnitedHealth Group Incorporated | 2.6% | 9.5% |
THC | Tenet Healthcare Corporation | 2.6% | 6.9% |
TMO | Thermo Fisher Scientific Inc. | 2.6% | -3.4% |
HCA | HCA Healthcare, Inc. | 2.5% | 11.2% |
WAT | Waters Corporation | 2.2% | -7% |
MMSI | Merit Medical Systems, Inc. | 2.1% | 8.7% |
JNJ | Johnson & Johnson | 2.1% | -13.6% |
JAZZ | Jazz Pharmaceuticals plc | 1.9% | 4.1% |
CHE | Chemed Corporation | 1.9% | 5.2% |
ICLR | ICON Public Limited Company | 1.5% | 5.7% |
HAE | Haemonetics Corporation | 1.4% | 10.1% |
CAH | Cardinal Health, Inc. | 1% | 8.8% |
HQY | HealthEquity, Inc. | 0.9% | 12.2% |
ASND | Ascendis Pharma A/S | 0.6% | 185.5% |
STVN | Stevanato Group S.p.A. | 0.5% | 7% |
ABT | Abbott Laboratories | 0.4% | 2.2% |
PEN | Penumbra, Inc. | 0.4% | 15.4% |
SYK | Stryker Corporation | 0.4% | 9.7% |
ACHC | Acadia Healthcare Company, Inc. | 0.3% | 9.1% |
CI | Cigna Corporation | 0.3% | 19.3% |
MEDP | Medpace Holdings, Inc. | 0.2% | 17.7% |
ENSG | The Ensign Group, Inc. | 0.1% | 10.8% |
NVO | Novo Nordisk A/S | - | 22.5% |
LNTH | Lantheus Holdings, Inc. | -0.2% | 23% |
IQV | IQVIA Holdings Inc. | -0.2% | 2.4% |
AZN | AstraZeneca PLC | -0.3% | 7.3% |
ABCM | Abcam plc | -0.3% | 9.7% |
PKI | PerkinElmer, Inc. | -0.3% | -42.3% |
QGEN | Qiagen N.V. | -0.5% | 2.2% |
TAK | Takeda Pharmaceutical Company Limited | -0.6% | 1.3% |
MCK | McKesson Corporation | -0.6% | 10.8% |
COR | Cencora | -0.9% | 7.8% |
ELV | Elevance Health Inc. | -1% | 1% |
DVA | DaVita Inc. | -1.2% | 6.9% |
SNN | Smith & Nephew plc | -1.3% | 5.9% |
BAX | Baxter International Inc. | -1.4% | -1.6% |
CNC | Centene Corporation | -1.5% | 3.9% |
FMS | Fresenius Medical Care AG & Co. KGaA | -1.7% | -0.2% |
BMRN | BioMarin Pharmaceutical Inc. | -1.9% | 9.4% |
ILMN | Illumina, Inc. | -2% | -1% |
CRL | Charles River Laboratories International, Inc. | -2.3% | -7.9% |
AMGN | Amgen Inc. | -2.3% | 21.1% |
LHCG | LHC Group, Inc. | -2.4% | -4.3% |
ABMD | Abiomed, Inc. | -2.5% | 7.2% |
KRYS | Krystal Biotech, Inc. | -2.6% | 轉虧為盈% |
STE | STERIS plc | -2.7% | 2.5% |
GSK | GSK plc | -3.3% | 5.9% |
CTLT | Catalent, Inc. | -3.7% | -10.9% |
BIO | Bio-Rad Laboratories, Inc. | -3.7% | -6.7% |
WBA | Walgreens Boots Alliance, Inc. | -3.8% | 6.3% |
BIIB | Biogen Inc. | -4% | -10.7% |
CVS | CVS Health Corporation | -4.1% | 3.7% |
VTRS | Viatris Inc. | -4.8% | -1.3% |
GEHC | GE HealthCare Technologies Inc. | -4.9% | -1.2% |
ABBV | AbbVie Inc. | -5.3% | 0.7% |
WST | West Pharmaceutical Services, Inc. | -5.3% | -3% |
RCM | R1 RCM Inc. | -5.5% | 10.7% |
INCY | Incyte Corporation | -5.5% | 8.9% |
MASI | Masimo Corporation | -6.4% | -12.8% |
TEVA | Teva Pharmaceutical Industries Limited | -8.7% | 4.3% |
EXEL | Exelixis, Inc. | -8.9% | 4% |
HZNP | Horizon Therapeutics Public Limited Company | -9% | 7.8% |
MTD | Mettler-Toledo International Inc. | -9.4% | -11.6% |
RGEN | Repligen Corporation | -9.8% | -17.1% |
HSIC | Henry Schein, Inc. | -9.9% | -10.5% |
SGEN | Seagen Inc. | -11% | 27.1% |
ROIV | Roivant Sciences Ltd. | -20.9% | 117.8% |
ITCI | Intra-Cellular Therapies, Inc. | -21% | 50.4% |
SGFY | Signify Health, Inc. | -24.4% | 11.9% |
LEGN | Legend Biotech Corporation | -47% | 187.6% |
NBIX | Neurocrine Biosciences, Inc. | -52.9% | 22.6% |
BNTX | BioNTech SE | -85.6% | -85.3% |
MRNA | Moderna, Inc. | -91.5% | -91% |
VKTX | Viking Therapeutics, Inc. | -100% | - |
ISEE | IVERIC bio, Inc. | - | - |
KRTX | Karuna Therapeutics, Inc. | - | -100% |
MDGL | Madrigal Pharmaceuticals, Inc. | - | - |
NUVL | Nuvalent, Inc. | - | - |
PCVX | Vaxcyte, Inc. | - | - |
